Literature DB >> 20146269

Synthesis of monomeric and dimeric repeating units of the zwitterionic type 1 capsular polysaccharide from Streptococcus pneumoniae.

Xiangyang Wu1, Lina Cui, Tomasz Lipinski, David R Bundle.   

Abstract

Zwitterionic polysaccharides (ZPSs) from Bacteroides fragilis and Streptococcus pneumoniae display unique T-cell activities. The first synthesis of a hexasaccharide representing two repeating units of the zwitterionic capsular polysaccharide from S. pneumoniae type 1 (Sp1) is reported. Key elements of the approach are stereoselective construction of 1,4-cis-alpha-galactose linkages based on a reactive trichloroacetimidate donor that incorporates a 6-O-acetyl group, which may contribute to the high alpha selectivity in glycosylation. After assembly of the fully protected hexasaccharide from five monosaccharide synthons 2-4, 24 and 25, selective deprotection of the primary hydroxyl groups of the four galactose residues followed by oxidation to the corresponding uronic acids provides hexasaccharide 19. The trisaccharide counterpart 1 was synthesized in similar fashion from three synthons, 2-4. This approach employed both conventional and dehydrative glycosylation methodologies and avoids the use of poorly reactive uronic acid derived glycosyl donors and acceptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146269     DOI: 10.1002/chem.200902460

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  11 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Chemoenzymatic synthesis of an isoprenoid phosphate tool for the analysis of complex bacterial oligosaccharide biosynthesis.

Authors:  Donovan K Lujan; Jennifer A Stanziale; Anahita Z Mostafavi; Sunita Sharma; Jerry M Troutman
Journal:  Carbohydr Res       Date:  2012-07-01       Impact factor: 2.104

4.  Automated glycan assembly of a S. pneumoniae serotype 3 CPS antigen.

Authors:  Markus W Weishaupt; Stefan Matthies; Mattan Hurevich; Claney L Pereira; Heung Sik Hahm; Peter H Seeberger
Journal:  Beilstein J Org Chem       Date:  2016-07-12       Impact factor: 2.883

5.  Synthesis of the Staphylococcus aureus Strain M Capsular Polysaccharide Repeating Unit.

Authors:  Bas Hagen; J Hessel M van Dijk; Qingju Zhang; Herman S Overkleeft; Gijsbert A van der Marel; Jeroen D C Codée
Journal:  Org Lett       Date:  2017-05-09       Impact factor: 6.005

6.  Total synthesis of a Streptococcus pneumoniae serotype 12F CPS repeating unit hexasaccharide.

Authors:  Peter H Seeberger; Claney L Pereira; Subramanian Govindan
Journal:  Beilstein J Org Chem       Date:  2017-01-25       Impact factor: 2.883

Review 7.  Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.

Authors:  Sharmeen Nishat; Peter R Andreana
Journal:  Vaccines (Basel)       Date:  2016-05-20

8.  Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1.

Authors:  Benjamin Schumann; Katrin Reppe; Paulina Kaplonek; Annette Wahlbrink; Chakkumkal Anish; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  ACS Cent Sci       Date:  2018-03-14       Impact factor: 14.553

Review 9.  Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates.

Authors:  Archanamayee Behera; Suvarn S Kulkarni
Journal:  Molecules       Date:  2018-08-10       Impact factor: 4.411

Review 10.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.